Omni Star Financial Group, Inc. Bristol Myers Squibb CO Transaction History

Omni Star Financial Group, Inc.

$126 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$40.25 - $52.99 $9,016 - $11,869	224 Added 1.71%	13,316 $553,000
Q1 2024 Apr 22, 2024	SELL	$47.98 - $54.4 $143,940 - $163,200	-3,000 Reduced 18.64%	13,092 $709,000
Q4 2023 Jan 17, 2024	SELL	$48.48 - $57.85 $289,958 - $346,000	-5,981 Reduced 27.1%	16,092 $825,000
Q3 2023 Nov 07, 2023	BUY	$57.89 - $64.73 $141,077 - $157,747	2,437 Added 12.41%	22,073 $1.28 Million
Q2 2023 Jul 24, 2023	BUY	$63.71 - $70.74 $81,485 - $90,476	1,279 Added 6.97%	19,636 $1.26 Million
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $93,111 - $105,609	1,417 Added 8.36%	18,357 $1.27 Million
Q4 2022 Jan 20, 2023	BUY	$68.48 - $81.09 $32,048 - $37,950	468 Added 2.84%	16,940 $0
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $351 - $207,698	-2,703 Reduced 14.1%	16,472 $1.17 Million
Q2 2022 Aug 03, 2022	BUY	$72.62 - $79.98 $137,687 - $151,642	1,896 Added 10.97%	19,175 $1.48 Million
Q1 2022 May 05, 2022	SELL	$61.48 - $73.72 $237,497 - $284,780	-3,863 Reduced 18.27%	17,279 $1.26 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $76,476 - $89,153	1,426 Added 7.23%	21,142 $1.32 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $85,086 - $99,667	1,438 Added 7.87%	19,716 $1.17 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $740,681 - $833,048	-12,482 Reduced 40.58%	18,278 $1.15 Million
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $660,256 - $748,192	-11,435 Reduced 27.1%	30,760 $1.91 Million
Q3 2020 Oct 22, 2020	BUY	$57.43 - $63.64 $29,289 - $32,456	510 Added 1.22%	42,195 $2.54 Million
Q2 2020 Jul 06, 2020	BUY	$54.82 - $64.09 $1.06 Million - $1.24 Million	19,397 Added 87.03%	41,685 $2.45 Million
Q1 2020 Apr 27, 2020	BUY	$46.4 - $67.43 $376,907 - $547,733	8,123 Added 57.35%	22,288 $1.24 Million
Q4 2019 Jan 13, 2020	SELL	$49.21 - $64.19 $646,078 - $842,750	-13,129 Reduced 48.1%	14,165 $909,000
Q3 2019 Oct 11, 2019	SELL	$42.77 - $50.71 $20,657 - $24,492	-483 Reduced 1.74%	27,294 $1.38 Million
Q2 2019 Jul 30, 2019	SELL	$44.62 - $49.34 $14,144 - $15,640	-317 Reduced 1.13%	27,777 $1.26 Million
Q1 2019 Apr 12, 2019	BUY	$45.12 - $53.8 $288,452 - $343,943	6,393 Added 29.46%	28,094 $1.34 Million
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $88,840 - $115,205	1,822 Added 9.17%	21,701 $1.13 Million
Q3 2018 Nov 16, 2018	BUY	$55.19 - $62.25 $1.1 Million - $1.24 Million	19,879 New	19,879 $1.23 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Omni Star Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Omni Star Financial Group, Inc. with notifications on news.

Account